Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations

Christine K Fox, Jeffrey Nelson, Charles E McCulloch, Shantel Weinsheimer, Ludmila Pawlikowska, Blaine Hart, Marc C Mabray, Atif Zafar, Leslie Morrison, Joseph M Zabramski, Amy Akers, Helen Kim, Christine K Fox, Jeffrey Nelson, Charles E McCulloch, Shantel Weinsheimer, Ludmila Pawlikowska, Blaine Hart, Marc C Mabray, Atif Zafar, Leslie Morrison, Joseph M Zabramski, Amy Akers, Helen Kim

Abstract

Background and objectives: Seizure incidence rates related to familial cerebral cavernous malformation (FCCM) are not well described, especially for children. To measure the seizure incidence rate, examine seizure predictors, and characterize epilepsy severity, we studied a cohort of children and adults with FCCM enrolled in the Brain Vascular Malformation Consortium (BVMC).

Methods: Seizure data were collected from participants with FCCM in the BVMC at enrollment and during follow-up. We estimated seizure probability by age and tested whether cerebral cavernous malformation (CCM) counts or genotype were associated with earlier seizure onset.

Results: The study cohort included 479 FCCM cases. Median age at enrollment was 42.5 years (interquartile range 22.5-55.0) and 19% were children (<18 years old). Median large CCM count was 3 (interquartile range 1-5). Among 393 with genotyping, mutations were as follows: CCM1 (Common Hispanic Mutation) (88%), another CCM1 mutation (5%), CCM2 mutations (5%), and CCM3 mutations (2%). Prior to or during the study, 202 (42%) had a seizure. The cumulative incidence of a childhood seizure was 20.3% (95% confidence interval [CI] 17.0-23.4) and by age 80 years was 60.4% (95% CI 54.2-65.7). More total CCMs (hazard ratio [HR] 1.24 per SD unit increase, 95% CI 1.1-1.4) or more large CCMs (HR 1.5 per SD unit increase, 95% CI 1.2-1.9) than expected for age and sex increased seizure risk. A CCM3 mutation also increased risk compared to other mutations (HR 3.11, 95% CI 1.15-8.45). Individuals with a seizure prior to enrollment had increased hospitalization rates during follow-up (incidence rate ratio 10.9, 95% CI 2.41-49.32) compared to patients without a seizure history.

Discussion: Individuals with FCCM have a high seizure incidence and those with more CCMs or CCM3 genotype are at greater risk. Seizures increase health care utilization in FCCM.

© 2021 American Academy of Neurology.

Figures

Figure. Cerebral Cavernous Malformation (CCM) Lesion Burden…
Figure. Cerebral Cavernous Malformation (CCM) Lesion Burden Predicts Seizure Risk in Children and Adults With Familial FCCM
A higher total number or a higher count of large CCMs (≥5 mm) is associated with an increased probability of earlier seizure, as illustrated by survival curves modeling the effects of lesion burden and age on seizure probability. (A, B) Effect of total CCM count on seizure cumulative incidence for individuals who have an average number of CCMs expected for their age (50% curve, blue) as well as those at the 10th and 90th percentiles of CCM counts (green and red curves, respectively). (C, D) Seizure cumulative incidence for individuals at the 10th, 50th, and 90th percentiles of large CCM counts expected for age. Individuals who enrolled at younger ages also had earlier seizures, illustrated by survival curves for children enrolled at 10 years of age (A and C) vs adults enrolled at 40 years of age (B and D).

References

    1. Josephson CB, Rosenow F, Al-Shahi Salman R. Intracranial vascular malformations and epilepsy. Semin Neurol. 2015;35(3):223-234.
    1. Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006;21(1):e7.
    1. Josephson CB, Leach JP, Duncan R, et al. . Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2011;76(18):1548-1554.
    1. Akers AL, Ball KL, Clancy M, et al. . Brain Vascular Malformation Consortium: overview, progress and future directions. J Rare Disord. 2013;1(1):5.
    1. Labauge P, Brunereau L, Laberge S, Houtteville JP. Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations. Neurology. 2001;57(10):1825-1828.
    1. Zabramski JM, Wascher TM, Spetzler RF, et al. . The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80(3):422-432.
    1. Taslimi S, Ku JC, Modabbernia A, Macdonald RL. Hemorrhage, seizures, and dynamic changes of familial versus nonfamilial cavernous malformation: systematic review and meta-analysis. World Neurosurg. 2019;126:241-246.
    1. Moriarity JL, Wetzel M, Clatterbuck RE, et al. . The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery. 1999;44(6):1166–1171; discussion 1172–1163.
    1. Sawarkar DP, Janmatti S, Kumar R, et al. . Cavernous malformations of central nervous system in pediatric patients: our single-centered experience in 50 patients and review of literature. Child's Nerv Syst. 2017;33(9):1525-1538.
    1. Aslan A, Borcek AO, Demirci H, Erdem MB. Cerebral cavernous malformation presenting in childhood: a single-centered surgical experience of 29 cases. Clin Neurol Neurosurg. 2020;194:105830.
    1. Choquet H, Pawlikowska L, Nelson J, et al. . Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity. Cerebrovasc Dis. 2014;38(6):433-440.
    1. Choquet H, Nelson J, Pawlikowska L, et al. . Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the Common Hispanic Mutation. Cerebrovasc Dis. 2014;37(1):57-63.
    1. Choquet H, Trapani E, Goitre L, et al. . Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in cerebral cavernous malformation type 1. Free Radic Biol Med. 2016;92:100-109.
    1. Fisher RS, Acevedo C, Arzimanoglou A, et al. . ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482.
    1. Rosenow F, Alonso-Vanegas MA, Baumgartner C, et al. . Cavernoma-related epilepsy: review and recommendations for management: report of the surgical task force of the ILAE commission on therapeutic strategies. Epilepsia. 2013;54(12):2025-2035.
    1. Trinka E, Cock H, Hesdorffer D, et al. . A definition and classification of status epilepticus: report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515-1523.
    1. Riant F, Bergametti F, Fournier HD, et al. . CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas. Mol Syndromol. 2013;4(4):165-172.
    1. Menzler K, Chen X, Thiel P, et al. . Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery. 2010;67(4):918-924.
    1. Casazza M, Broggi G, Franzini A, et al. . Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery. 1996;39(1):26-32; discussion 32–24.
    1. Agosti E, Flemming KD, Lanzino G. Symptomatic cavernous malformation presenting with seizure without hemorrhage: analysis of factors influencing clinical presentation. World Neurosurg. 2019;129:e387-e392.
    1. Polster SP, Stadnik A, Akers AL, et al. . Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) trial. Neurosurgery. 2019;85(6):843-853.
    1. Gibson CC, Zhu W, Davis CT, et al. . Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation. 2015;131(3):289-299.
    1. Modi AC, King AS, Monahan SR, Koumoutsos JE, Morita DA, Glauser TA. Even a single seizure negatively impacts pediatric health-related quality of life. Epilepsia. 2009;50(9):2110-2116.
    1. Kaur J, Paul BS, Goel P, Singh G. Educational achievement, employment, marriage, and driving in adults with childhood-onset epilepsy. Epilepsy Behav. 2019;97:149-153.
    1. Jennum P, Debes NMM, Ibsen R, Kjellberg J. Long-term employment, education, and healthcare costs of childhood and adolescent onset of epilepsy. Epilepsy Behav. 2020;114(pt A):107256.
    1. Mbizvo GK, Bennett K, Simpson CR, Duncan SE, Chin RFM. Epilepsy-related and other causes of mortality in people with epilepsy: a systematic review of systematic reviews. Epilepsy Res. 2019;157:106192.

Source: PubMed

3
订阅